Localization of calponin binding sites in the structure of 90 kDa heat shock protein (Hsp90)  by Bogatcheva, Natalia V et al.
Localization of calponin binding sites in the structure of 90 kDa heat
shock protein (Hsp90)
Natalia V. Bogatcheva, YuShu Ma, Dunja Urosev, Nikolai B. Gusev*
Department of Biochemistry, School of Biology, Moscow State University, Moscow 119899, Russia
Received 21 July 1999
Abstract The structure of rabbit liver Hsp90 was reevaluated
by limited trypsinolysis, N-terminal sequencing and determina-
tion of the site that is phosphorylated by casein kinase II.
Limited proteolysis results in formation of four groups of large
peptides with Mr in the range of 26^41 kDa. Peptides with Mr
39^41 kDa were represented by large N-terminal and central
peptides starting at residue 283 of the K-isoform of Hsp90. All
sites phosphorylated by casein kinase II were located in the large
39^41 kDa peptides. Peptides with Mr 26^27 kDa were
represented by short N-terminal and central peptides starting
at Glu-400 of the K-isoform of Hsp90. The data of affinity
chromatography and light scattering indicate that smooth muscle
calponin interacts with Hsp90. The calponin binding sites are
located in the large (37^41 kDa) N-terminal and in a short (26^
27 kDa) central peptide starting at Glu-400 of the K-isoform of
Hsp90. Phosphorylation by casein kinase II up to 2 mol of
phosphate per mol of Hsp90 does not affect interaction of Hsp90
with calponin.
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1. Introduction
The cytosolic 90 kDa heat shock protein (Hsp90) is highly
conserved, constitutively expressed abundant protein of eu-
karyotes [1,2]. Hsp90 interacts with many proteins and in
this way prevents their aggregation, provides for proper fold-
ing or is involved in tra⁄cking of certain proteins to their
destination [1,2]. Localization of the sites involved in the in-
teraction of Hsp90 with its substrate proteins is important for
understanding of the molecular mechanism of action of this
chaperone. Hsp90 interacts with steroid receptors and it is
believed that at least two sites located in the N-terminal and
central [3] or in the central and C-terminal [4] parts of Hsp90
participate in this interaction. Hsp90 interacts with a number
of protein kinases [1,2], but the sites of its interaction with
protein kinases are not precisely determined. Calmodulin
binds to Hsp90 and the calmodulin binding sites of mouse
Hsp90 are located in the central part of the molecule [5,6].
Intact Hsp90 prevents aggregation of denatured rhodanase.
Two short peptides containing N-terminal (residues 1^236)
or C-terminal (residues 629^732) fragments of Hsp90 are
also e¡ective in preventing aggregation of denatured rhoda-
nase [7]. Although both the N-terminal and C-terminal frag-
ments of Hsp90 prevent aggregation of denatured luciferase,
only the C-terminal fragment of Hsp90 maintains the un-
folded luciferase in a state competent for refolding [7]. Similar
results were obtained on denatured insulin and citrate syn-
thase [8]. These experiments indicate that for some protein
substrates there are two independent chaperone sites located
in the N- and C-terminal parts of Hsp90 [7,8].
It is well known that Hsp90 interacts with the cytoskeleton
[2]. Hsp90 binds actin [9] and under certain conditions asso-
ciates with microtubules, intermediate ¢laments and micro¢la-
ments [10]. Smooth muscle calponin is an actin binding pro-
tein which seems to be involved in the regulation of
actomyosin ATPase, polymerization of G-actin and reorgan-
ization of the cytoskeleton [11]. In addition calponin is some-
how involved in targeting of protein kinase C and mitogen-
associated protein kinase to the cell membrane after chemical
stimulation [12]. Taking into account the high concentration
of Hsp90 in the cell [13] and its preferential interaction with
basic substrates [14] we supposed that Hsp90 interacts with
calponin and in this way may modulate calponin-induced re-
organization of actin ¢laments [15,16]. We found that calpo-
nin can be crosslinked to Hsp90 [15]. Binding to Hsp90 a¡ects
calponin-induced bundling of actin ¢laments [16] and poly-
merization of G-actin (unpublished results). Thus, our in vitro
results indicate that calponin may interact with Hsp90 and
this interaction may be of physiological signi¢cance. In order
to understand the mechanism of interaction of calponin with
Hsp90 we tried to localize the calponin binding site of Hsp90
and to analyze the e¡ect of phosphorylation of Hsp90 on its
interaction with calponin.
2. Materials and methods
Rabbit liver Hsp90, duck gizzard calponin and rat liver casein ki-
nase II were puri¢ed by earlier described methods [15,17,18]. Protein
concentration was determined spectrophotometrically taking E0:1%280
equal to 0.86 for Hsp90 [19] and 0.78 for calponin [20]. In some
experiments the protein concentration was determined by the method
of Spector [21].
Two methods were used for analyzing the interaction of Hsp90 with
calponin. Binding of calponin to Hsp90 was followed by measuring
light scattering at 340 nm a in Hitachi F-3000 spectro£uorometer.
Aliquots of calponin were added to 1 ml samples containing 20 mM
Tris-HCl, pH 7.4, in the presence or absence of Hsp90. The increase
in light scattering (vIs) was plotted against the total concentration of
calponin added. A⁄nity chromatography was also used for analysis
of the calponin-Hsp90 interaction. Calponin was immobilized on
CNBr-activated Sepharose (Pharmacia) according to the procedure
recommended by the supplier. Under the conditions used 2 mg of
calponin were bound per 1 g of dry Sepharose. Phosphorylated or
unphosphorylated Hsp90 (0.2^0.3 mg) was loaded on the column of
calponin-Sepharose (3.0 ml) equilibrated by 20 mM Tris-HCl, pH 7.5,
75 mM NaCl. The column was washed by equilibrating bu¡er and
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Hsp90 bound to the column was eluted by the same bu¡er containing
300 mM NaCl. Since the samples of Hsp90 loaded on the column
contained ATP, elution was followed by measuring the protein con-
centration by the dye binding method of Spector [21]. When the
tryptic digest of Hsp90 was subjected to a⁄nity chromatography
the column of calponin-Sepharose was equilibrated by 20 mM Tris-
HCl containing 25 mM NaCl and peptides bound to the matrix were
eluted by the same bu¡er containing 300 mM NaCl. The composition
of the fractions loaded on the a⁄nity matrix and interacting with
immobilized calponin was determined by SDS-gel electrophoresis
and the peptides were detected on the gel using a silver staining kit
(Sigma).
Phosphorylation of Hsp90 (0.4 mg/ml) by casein kinase II (0.01 mg/
ml) was performed in 8 mM Tris-12 mM KH2PO4 (pH 7.0), 5 mM
MgCl2, 80^160 WM ATP containing [Q-32P]ATP (0.1 mCi/ml). The
samples were incubated at 37‡C for 45^60 min and the reaction was
stopped by addition of 1/10 volume of heparin-Sepharose. Casein
kinase II bound to heparin-Sepharose was removed by low speed
centrifugation. Phosphorylated Hsp90 was either directly loaded on
the column of calponin-Sepharose or subjected to trypsinolysis. In
order to analyze the e¡ect of phosphorylation of Hsp90 on its inter-
action with calponin we loaded both phosphorylated and unphos-
phorylated Hsp90 on the column of calponin-Sepharose. The unphos-
phorylated Hsp90 was obtained as follows. Hsp90 was incubated in
the bu¡er of phosphorylation without ATP and casein kinase II under
conditions described earlier. ATP was added to the sample of unphos-
phorylated Hsp90 just before loading on the column of calponin-Se-
pharose or just before titration by calponin in the light scattering
experiments.
Limited trypsinolysis was performed in 20 mM Tris-HCl, pH 7.5,
0.2 mM L-mercaptoethanol at a weight ratio of Hsp90/TPCK-treated
trypsin equal to 150/1. The incubation lasted for 5^20 min at 35‡C
and the reaction was stopped by addition of phenylmethylsulfonyl
£uoride (up to a ¢nal concentration of 1 mM). The peptide mixture
was either directly subjected to SDS-gel electrophoresis [22] or sepa-
rated by a⁄nity chromatography on calponin-Sepharose which was
followed by SDS-gel electrophoresis. After electrophoresis the frag-
ments of Hsp90 were transferred to polyvinylidene di£uoride (PVD)
membranes (Sigma). The protein bands visualized with Coomassie R-
250 were subjected to N-terminal sequencing with a model 491 cLC
protein sequencer (Perkin-Elmer Applied Biosystems).
Exhaustive trypsinolysis of Hsp90 phosphorylated by casein kinase
II was performed in 100 mM NH4HCO3, 5 mM MgCl2 at a weight
ratio of Hsp90/TPCK-treated trypsin equal to 50/1. After overnight
incubation at 37‡C the reaction was stopped by addition of a mixture
of tri£uoroacetid acid (TFA) and EDTA up to ¢nal concentrations of
1% and 1 mM respectively. The mixture of peptides was freeze-dried,
dissolved in 0.05% TFA and loaded on an Ultrasphere ODS 18 col-
umn (4.6U250 mm). Elution by a linear gradient (0^50%) of acetoni-
trile in 0.05% TFA results in two major radioactive peaks. The ¢rst
peak was rechromatographed on the same column using a shallow (0^
21%) gradient of acetonitrile. The puri¢ed radioactive peptide was
transferred to the PVD membrane and sequenced with 477 A protein
sequencer (Applied Biosystems). The second peak was lost during
further puri¢cation due to its poor solubility.
Since the complete primary structure of rabbit liver Hsp90 is un-
known we used numbering corresponding to the primary structure of
human K- or L-isoform of Hsp90 (P07900 or P08238 respectively)
from the Swiss-Prot data bank. Computer analysis of the primary
structure and physico-chemical properties of Hsp90 peptides was per-
formed by the PC GENE program package (subprogram PHYS-
CHEM).
3. Results
3.1. Identi¢cation of tryptic peptides of Hsp90
Limited trypsinolysis of Hsp90 results in the formation of a
number of peptides with Mr in the range of 14^41 kDa (Fig.
1A). These peptides can be separated into six groups. Four
groups of high molecular weight peptides form doublets with
Mr 39^41 kDa (group 1), 37^38 kDa (group 2), 31^32 kDa
(group 3) and 26^27 kDa (group 4). Two groups of low mo-
lecular weight peptides migrate with Mr 17^18 kDa (group 5)
and 14^15 kDa (group 6). The overall pattern of trypsinolysis
is similar to that described in the literature [23^26]. However,
there are still problems in attributing di¡erent peptides to
certain domains in the Hsp90 structure. For example, peptides
with Mr 39^41 kDa are supposed to be presented either by the
N-terminal peptide [24,25] or by the peptides starting at Tyr-
283 of the K-isoform of human Hsp90 [23]. Lees-Miller and
Anderson [23] and Nemoto et al. [25] supposed that peptides
with Mr 30^33 kDa are represented by the N-terminal pep-
tides of Hsp90, whereas the data of Itoh and Tashima [24]
indicate that this band contains peptides starting at Tyr-283.
In order to localize the position of tryptic peptides in the
structure of Hsp90 we determined the N-terminal sequence
of some of these peptides.
The ¢rst group of peptides with Mr 39^41 kDa revealed two
sequences, namely PEETQ and YIDQX. These sequences cor-
respond to the N-terminal peptide of the K-isoform of Hsp90
and to the peptide starting at Tyr-283 of the K- or Tyr-275 of
the L-form of Hsp90 (Table 1). The peptides of the second
group (Mr 37^38 kDa) form a rather di¡use zone on the SDS-
gel electrophoresis and contained bands di¡erently stained by
silver. Since these peptides were not homogeneous and were
poorly separated on the SDS-gel electrophoresis we did not
try to determine their N-terminal sequence. (A⁄nity chroma-
tography on calponin-Sepharose showed that peptides migrat-
ing in this zone were indeed heterogeneous. One component
of this mixture is represented by the N-terminal peptide with
the N-terminal sequence PEEVH corresponding to residues 1^
5 of the L-isoform of Hsp90.) The third group of peptides
with Mr 31^32 kDa was also heterogeneous. One of the com-
ponents of this mixture revealed the sequence PEETQ once
again corresponding to the N-terminus of the K-isoform of
Hsp90. The N-terminal sequences of the fourth group of pep-
tides migrating with Mr 26^27 kDa were EMLQQ and
PXEVX. The ¢rst sequence corresponds to peptides starting
at Glu-400 of the K- or Glu-392 of the L-isoform of human
Hsp90. The second sequence (PXEVX) corresponds to the N-
terminus of the L-isoform of Hsp90 (Table 1).
If Hsp90 phosphorylated by casein kinase II was subjected
Fig. 1. Tryptic peptide mapping of rabbit liver Hsp90 phosphoryl-
ated by casein kinase II (about 1 mol of phosphate per mol of
Hsp90). A: SDS-gel electrophoresis of intact Hsp90 (1) and its tryp-
tic peptides obtained after 5 (2) and 20 (3) min incubation with
trypsin. B: Autoradiogram of lane 3.
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to limited trypsinolysis and subsequent SDS-gel electrophore-
sis the whole radioactivity was detected in the doublet of
largest peptides with Mr 39^41 kDa (Fig. 1B). When Hsp90
phosphorylated by casein kinase II was exhaustively cleaved
by trypsin and phosphorylated peptides were separated by
reverse phase HPLC we detected two main radioactive pep-
tides. About 15% of radioactivity incorporated by casein ki-
nase II was detected in the peptide having the N-terminal
sequence IEDVX. This sequence corresponds to the tryptic
peptide starting at Lys-248 of the L-isoform of human
Hsp90. This peptide contains Ser-254 in the sequence SDEED
that ideally corresponds to the motif phosphorylated by casein
kinase II [27]. The K-isoform of Hsp90 has an identical pri-
mary structure at Ser-262, which is homologous to Ser-254 of
the L-isoform. The second radioactive peptide was poorly
soluble and we failed to determine its primary structure. In
any case, our data mean that at least one site phosphorylated
by casein kinase II is located in the N-terminal part of Hsp90.
Based on the data of SDS-gel electrophoresis, N-terminal
sequencing and location of the sites of phosphorylation we
tried to reevaluate the localization of tryptic peptides in the
primary structure of Hsp90. The data in the literature [23^25]
indicate that there are three main sites of trypsinolysis located
approximately at residues 282, 399 and 614/616 of the K-iso-
form of Hsp90 (Fig. 2). The cleavage at these sites produces
N-terminal (residues 1^282, 1^399), central (residues 283^614/
616, 400^614/616) and C-terminal (residues 615/620^732) pep-
tides. The C-terminal end of the large N-terminal peptides is
susceptible to further trypsinolysis and contains highly £exible
and surface-exposed region (residues 227^310) [25]. This leads
to accumulation of a number of N-terminal peptides with Mr
in the range of 26^41 kDa (Fig. 2). One of the sites phos-
phorylated by casein kinase II is Ser-254/Ser-262 of Hsp90.
This means that all N-terminal peptides containing the ¢rst
260^270 residues with an estimated molecular weight of 30^32
kDa should contain radioactive phosphate. In contrast, we
found that only peptides with Mr 39^41 kDa contained sites
of phosphorylation whereas the second and the third groups
of peptides with Mr 31^38 kDa (containing among others the
N-terminal fragments) were not radioactive (Fig. 1B). This
discrepancy can be explained by the fact that the N-terminal
part of Hsp90 is highly acidic (the calculated pI value of the
peptide containing residues 1^300 of the K-isoform of Hsp90
is equal to 4.44). Acidic proteins anomalously interact with
SDS and have a lower mobility on SDS-gel electrophoresis
[28]. Therefore we might expect that the N-terminal peptides
would migrate with an anomalously high molecular weight on
SDS-gel electrophoresis. Indeed we found that the N-terminal
peptide containing 282 residues and the central peptide (resi-
dues 283^614/619) containing more than 330 residues (Fig. 2)
Fig. 2. Hypothetical scheme of trypsinolysis of the K-isoform of Hsp90. Full-length Hsp90 and its fragments are represented as proportional
rectangles with their Mr values in kDa. Two heavy arrows (K282 and R399) indicate preferential sites of trypsinolysis detected in this paper.
The light arrow (K614/K619) indicates the preferential site of trypsinolysis detected by Nemoto et al. [25]. Highly £exible immunogenic regions
(227^310 and 702^716) were described by Nemoto et al. [25]. Black rectangles with labeling of N-terminal amino acids show peptides character-
ized in this paper. One of the sites phosphorylated by casein kinase II (Ser-262) is labeled with a P. Peptides with Mr 31^38 kDa (groups II
and III) are heterogeneous, and only peptides with determined N-terminal sequence are represented in the scheme.
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migrated on SDS-gel electrophoresis with similar Mr of 39^41
kDa (Table 1, Fig. 2).
As mentioned earlier, two groups of peptides migrating
with Mr 37^38 and 31^32 kDa contained a complex mixture
of di¡erent peptides. N-terminal sequencing revealed the pres-
ence of the N-terminal peptides in both 37^38 and 31^32 kDa
bands, but we cannot exclude the presence of other peptides in
these mixtures. The fourth group of peptides migrating with
Mr 26^27 kDa on SDS-gel electrophoresis may also consist of
a mixture of short N-terminal and central peptides containing
residues 400^614/616 (Table 1, Fig. 2).
3.2. Localization of calponin binding sites of Hsp90
The method of a⁄nity chromatography was used for local-
ization of calponin binding sites of Hsp90. To avoid weak
electrostatic interaction between acidic Hsp90 (pI 5.4) and
basic calponin (pI 9.0) we equilibrated the column of calpo-
nin-Sepharose with bu¡er containing 20 mM Tris-HCl, pH
7.5, 25 mM NaCl. If the protein mixture containing Hsp90
and a ¢ve-fold weight excess of bovine serum albumin was
loaded on the calponin-Sepharose, Hsp90 was quantitatively
retarded on the column whereas the vast majority of albumin
was detected in the £ow-through. Thus, among two proteins
having similar pI only Hsp90 was speci¢cally bound to calpo-
nin-Sepharose. Therefore a⁄nity chromatography seems to be
the method of choice for determination of calponin binding
sites of Hsp90.
When the mixture of tryptic peptides of Hsp90 was loaded
on the column, only high molecular weight peptides were
bound to the a⁄nity matrix whereas all short tryptic peptides
with Mr of 17^19 and 14^15 kDa were detected in the £ow-
through (Fig. 3). The peptides retarded on the column were
subjected to SDS-gel electrophoresis, transferred to the PVD
membrane and sequenced on the protein sequencer. Analysis
of the peptide doublet with Mr 39^41 kDa retarded on calpo-
nin-Sepharose revealed the sequence PEEVH corresponding
to residues 1^5 of the L-isoform of Hsp90. Part of the peptides
having Mr in the range of 37^38 kDa was not bound to
immobilized calponin (Fig. 3). The portion of these peptides
retarded on the a⁄nity matrix has the N-terminal sequence
PEEVH. This means that these peptides also derive from the
very N-terminal part of Hsp90. We detected multiple peptides
with Mr in the range of 31^32 kDa (Fig. 3). Part of these
peptides were not bound to immobilized calponin, whereas
other peptides having a similar molecular weight were tightly
bound to calponin. Unfortunately, this fraction was heteroge-
neous and we failed to determine its N-terminal sequence.
Only one N-terminal sequence was detected for peptides hav-
ing Mr 27 kDa and retarded on calponin-Sepharose. The se-
quence EMLQQ corresponds to peptides starting at residue
392 of the L- or 400 of the K-isoform of Hsp90.
The data presented mean that the large N-terminal peptides
having Mr 37^41 kDa and a rather short (Mr 27^29 kDa)
peptide derived from the central portion of the molecule
and starting at residues 392/400 of Hsp90 were able to interact
with calponin.
3.3. E¡ect of phosphorylation of Hsp90 on its interaction with
calponin
Since the N-terminal part of Hsp90 containing the sites
phosphorylated by casein kinase II seems to be involved in
Fig. 3. Identi¢cation of tryptic peptides of Hsp90 interacting with
calponin. SDS-gel electrophoresis of the initial mixture of tryptic
peptides of Hsp90 loaded on the calponin-Sepharose column (1),
peptides which were not retarded on the a⁄nity matrix (2) and pep-
tides bound on calponin-Sepharose and eluted by 300 mM NaCl
(3).
Fig. 4. Titration of 400 nM unphosphorylated (circles) and phos-
phorylated (2 mol phosphate/mol protein) (triangles) Hsp90 by cal-
ponin. Light scattering induced by addition of calponin to the con-
trol sample without Hsp90 is shown by the curve labeled by
squares. The increase in light scattering at 340 nm (vIs) is plotted
against the total concentration of calponin added.
Table 1
N-terminal sequencing of proteolytic fragments of rabbit liver
Hsp90
Peptide Mr
(kDa)
Detected
amino acids
Corresponding sequence in
Hsp90
39^41 PEETQ 1PEETQ5 (K-isoform)
YIDQE 283YIDQE287 (K-isoform)
275YIDQE279 (L-isoform)
37^38 Not determined
31^32 PEETQ 1PEETQ5 (K-isoform)
26^27 EMLQQ 400EMLQQ405 (K-isoform)
PXEVX 392EMLQQ396 (L-isoform)
1PEEVH5 (L-isoform)
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the interaction with calponin, we analyzed the e¡ect of phos-
phorylation on the binding of Hsp90 to immobilized calponin.
Under the conditions used casein kinase II transferred more
than 2 mol of phosphate per mol of Hsp90. All phosphate
incorporated by casein kinase II was detected in the largest
39^41 kDa tryptic peptides of Hsp90 (Fig. 1).
When an excess of unphosphorylated Hsp90 in the presence
of 0.1 mM ATP was loaded on the column of immobilized
calponin (equilibrated by bu¡er containing 75 mM NaCl),
about 80% was detected in the £ow-through and 20% was
bound to the a⁄nity matrix (data not shown). Similar results
were obtained with Hsp90 phosphorylated by casein kinase II.
Thus, under the conditions used phosphorylation of Hsp90
does not a¡ect its binding to immobilized calponin. Similar
results were obtained by the method of light scattering. Titra-
tion of Hsp90 by calponin is accompanied by an increase in
light scattering which is signi¢cantly larger than the scattering
induced by addition of calponin to the control sample without
Hsp90 (Fig. 4). Therefore we may suppose that the increase in
light scattering re£ects the interaction of calponin with Hsp90.
Since the titration curves obtained with phosphorylated (2
mol phosphate per mol of protein) and non-phosphorylated
Hsp90 were very similar, we suppose that phosphorylation by
casein kinase II does a¡ect the interaction of Hsp90 with
calponin.
4. Discussion
Proteolysis was successfully used for analysis of the struc-
ture of Hsp90 [23^26]. It is supposed that there are two main
sites of proteolytic cleavage of Hsp90 located around residues
360^400 and 600^620 [25,26]. Cleavage at these sites results in
accumulation of large (40^50 kDa) N-terminal, intermediate
(22^27 kDa) central and short (about 15 kDa) C-terminal
fragments. One additional preferential site of cleavage de-
tected in this investigation and in a number of other papers
[23,24] is Lys-282 of the K-isoform of Hsp90 (see Fig. 2). The
presence of at least three main sites of trypsinolysis together
with the susceptibility of large tryptic fragments to further
degradation from their C-terminal ends [25] leads to accumu-
lation of a set of tryptic peptides with similar molecular
weight derived from completely di¡erent regions of Hsp90.
For instance, the largest 39^41 kDa peptides may be pre-
sented by both the N-terminal and central peptides (Fig. 2)
and the same is true for practically all groups of peptides. This
partly explains the discrepancy in the literature when peptides
having similar molecular weights were attributed to di¡erent
parts of Hsp90. For example the largest peptides with Mr 39^
41 kDa were attributed to the N-terminal [25] or to the central
part [23] of Hsp90.
In order to determine the sites of Hsp90 involved in the
binding of calponin we used the method of a⁄nity chroma-
tography (Fig. 3). The peptides retarded on immobilized cal-
ponin derived from the N-terminal (peptides with Mr 37^41
kDa) or from the central (peptides with Mr 26^27 kDa) part
of Hsp90 (Figs. 2 and 3). As mentioned earlier, the N-terminal
part of Hsp90 is highly acidic and the pI value of the peptide
containing the ¢rst 300 residues is equal to 4.44. Therefore
binding of acidic N-terminal fragments of Hsp90 to basic
calponin having pI 9.6 is at least partially based on electro-
static interactions. The calculated pI value of the central pep-
tide of Hsp90 restricted by residues 400^614 is equal to 8.5.
Therefore interaction of this peptide with calponin cannot be
primarily dependent on electrostatic interactions.
At present it is more or less accepted that Hsp90 contains
two chaperone sites in the N- and the C-terminal parts of the
molecule [7,8] and some of the potential substrates have at
least two binding sites on Hsp90 [3,4,7,8]. Our results with the
extremely basic calponin corroborate this point of view and
indicate that either Hsp90 has only one extended calponin
binding site (covering approximately residues 1^620 of
Hsp90) or two di¡erent sites located in the N-terminal and
the central parts of molecule. We also cannot exclude the
possibility that the calponin binding site of Hsp90 is formed
by short stretches of amino acids belonging to the N-terminal
and central peptides which approach each other in the tertiary
structure of Hsp90.
Hsp90 is copuri¢ed with casein kinase II and this protein
kinase seems to be involved in Hsp90 phosphorylation [29].
Lees-Miller and Anderson [23] found that Ser-231 and Ser-263
were the primary sites phosphorylated by casein kinase in the
K-isoform of Hsp90, whereas Rose et al. [30] detected the sites
of phosphorylation in the peptide corresponding to residues
55^68 of the L-isoform of Hsp90. In agreement with the data
of Lees-Miller and Anderson [23], we found that one of the
sites phosphorylated in Hps90 indeed corresponded to Ser-254
of the L- or to Ser-263 of the K-isoform of Hsp90. In our case
radioactive phosphate was detected only in a rather large N-
terminal peptides with Mr 39^41 kDa. The mixture of tryptic
peptides of Hsp90 contains a number of short N-terminal
fragments (with Mr 26^32 kDa) but neither of them contained
sites of phosphorylation (Figs. 1 and 2). These results contra-
dict the data of Rose et al. [30] and indicate that the main
sites of phosphorylation are located in the surface £exible
region in the C-terminal part of the large N-terminal peptides
of Hsp90.
Since the sites of phosphorylation were located in the N-
terminal part of Hsp90 close to the potential sites of calponin
binding we analyzed the e¡ect of Hsp90 phosphorylation on
its interaction with calponin. The data of a⁄nity chromatog-
raphy and light scattering indicate that phosphorylation of
Hsp90 by casein kinase II (up to 2 mol of phosphate per
mol of protein) has no signi¢cant e¡ect on the binding of
calponin (Fig. 4). Although the role of phosphorylation of
Hsp90 remains enigmatic some data in the literature indicate
that phosphorylation of Hsp90 may a¡ect its interaction with
pp60src [31]. We may suppose that either interaction of Hsp90
with calponin is independent of Hsp90 phosphorylation or
protein kinases other than casein kinase II participate in the
regulation of this interaction.
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